Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Crizotinib hydrochloride

😃Good
Catalog No. T8399Cas No. 1415560-69-8
Alias PF-02341066 hydrochloride

Crizotinib hydrochloride (PF-02341066 hydrochloride) is a novel inhibitor of anaplastic lymphoma kinase and c-Met, with IC50 values of 20 nM and 8 nM, respectively.

Crizotinib hydrochloride

Crizotinib hydrochloride

😃Good
Purity: 98.87%
Catalog No. T8399Alias PF-02341066 hydrochlorideCas No. 1415560-69-8
Crizotinib hydrochloride (PF-02341066 hydrochloride) is a novel inhibitor of anaplastic lymphoma kinase and c-Met, with IC50 values of 20 nM and 8 nM, respectively.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$31In StockIn Stock
10 mg$48In StockIn Stock
25 mg$75In StockIn Stock
50 mg$101In StockIn Stock
100 mg$140In StockIn Stock
200 mg$174-In Stock
500 mg$239-In Stock
1 mL x 10 mM (in DMSO)$54In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.87%
Appearance:Solid
Color:Yellow to Brown
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Crizotinib hydrochloride (PF-02341066 hydrochloride) is a novel inhibitor of anaplastic lymphoma kinase and c-Met, with IC50 values of 20 nM and 8 nM, respectively.
Targets&IC50
ALK:20 nM , c-Met:8 nM
In vitro
Crizotinib hydrochloride(PF-2341066)potently inhibited NPM-ALK phosphorylation in Karpas299 or SU-DHL-1 ALCL cells (mean IC(50) value, 24 nmol/L).?In biochemical and cellular screens, PF-2341066 was shown to be selective for c-Met and ALK at pharmacologically relevant concentrations across a panel of >120 diverse kinases.?PF-2341066 potently inhibited cell proliferation, which was associated with G(1)-S-phase cell cycle arrest and induction of apoptosis in ALK-positive ALCL cells (IC(50) values, approximately 30 nmol/L) but not ALK-negative lymphoma cells[1].
SynonymsPF-02341066 hydrochloride
Chemical Properties
Molecular Weight486.8
FormulaC21H23Cl3FN5O
Cas No.1415560-69-8
SmilesCl.C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl
Relative Density.no data available
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 10 mg/mL (20.54 mM), Sonication is recommended.
H2O: 50 mg/mL (102.71 mM), Sonication is recommended.
Solution Preparation Table
DMSO/H2O
1mg5mg10mg50mg
1 mM2.0542 mL10.2712 mL20.5423 mL102.7116 mL
5 mM0.4108 mL2.0542 mL4.1085 mL20.5423 mL
10 mM0.2054 mL1.0271 mL2.0542 mL10.2712 mL
20 mM0.1027 mL0.5136 mL1.0271 mL5.1356 mL
H2O
1mg5mg10mg50mg
50 mM0.0411 mL0.2054 mL0.4108 mL2.0542 mL
100 mM0.0205 mL0.1027 mL0.2054 mL1.0271 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Crizotinib hydrochloride | purchase Crizotinib hydrochloride | Crizotinib hydrochloride cost | order Crizotinib hydrochloride | Crizotinib hydrochloride chemical structure | Crizotinib hydrochloride in vitro | Crizotinib hydrochloride formula | Crizotinib hydrochloride molecular weight